Cargando…

Neuronal pentraxin 2 is required for facilitating excitatory synaptic inputs onto spinal neurons involved in pruriceptive transmission in a model of chronic itch

An excitatory neuron subset in the spinal dorsal horn (SDH) that expresses gastrin-releasing peptide receptors (GRPR) is critical for pruriceptive transmission. Here, we show that glutamatergic excitatory inputs onto GRPR(+) neurons are facilitated in mouse models of chronic itch. In these models, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanehisa, Kensho, Koga, Keisuke, Maejima, Sho, Shiraishi, Yuto, Asai, Konatsu, Shiratori-Hayashi, Miho, Xiao, Mei-Fang, Sakamoto, Hirotaka, Worley, Paul F., Tsuda, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061767/
https://www.ncbi.nlm.nih.gov/pubmed/35501343
http://dx.doi.org/10.1038/s41467-022-30089-x
Descripción
Sumario:An excitatory neuron subset in the spinal dorsal horn (SDH) that expresses gastrin-releasing peptide receptors (GRPR) is critical for pruriceptive transmission. Here, we show that glutamatergic excitatory inputs onto GRPR(+) neurons are facilitated in mouse models of chronic itch. In these models, neuronal pentraxin 2 (NPTX2), an activity-dependent immediate early gene product, is upregulated in the dorsal root ganglion (DRG) neurons. Electron microscopy reveals that NPTX2 is present at presynaptic terminals connected onto postsynaptic GRPR(+) neurons. NPTX2-knockout prevents the facilitation of synaptic inputs to GRPR(+) neurons, and repetitive scratching behavior. DRG-specific NPTX2 expression rescues the impaired behavioral phenotype in NPTX2-knockout mice. Moreover, ectopic expression of a dominant-negative form of NPTX2 in DRG neurons reduces chronic itch-like behavior in mice. Our findings indicate that the upregulation of NPTX2 expression in DRG neurons contributes to the facilitation of glutamatergic inputs onto GRPR(+) neurons under chronic itch-like conditions, providing a potential therapeutic target.